Smart Nanotherapeutics and Lung Cancer
Lung cancer is a significant health problem worldwide. Unfortunately, current therapeutic strategies lack a sufficient level of specificity and can harm adjacent healthy cells. Consequently, to address the clinical need, novel approaches to improve treatment efficiency with minimal side effects are...
Saved in:
Main Authors: | Mohammad Doroudian (Author), Mohammad H. Azhdari (Author), Nima Goodarzi (Author), David O'Sullivan (Author), Seamas C. Donnelly (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease
by: Dhruv R. Seshadri, et al.
Published: (2018) -
Lipid-engineered nanotherapeutics for cancer management
by: Alicia Fernandez-Fernandez, et al.
Published: (2023) -
Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics
by: Rachna M. Kumar, et al.
Published: (2023) -
Nanotherapeutics to Overcome Conventional Cancer Chemotherapy Limitations
by: Moorthi Chidambaram, et al.
Published: (2011) -
Nanotherapeutics targeting autophagy regulation for improved cancer therapy
by: Yunmeng Liu, et al.
Published: (2024)